Literature DB >> 30190855

Analysis of melanoma recurrence following a negative sentinel lymph node biopsy.

Maggie Hodges1, Edward Jones1, Teresa Jones1, Nathan Pearlman1, Csaba Gajdos1, Nicole Kounalakis1, Martin McCarter1.   

Abstract

Little attention has been paid to the characteristics and outcomes of patients who experience distant, local or regional recurrence of melanoma following a negative sentinel lymph node biopsy. This article aims to review the published literature on the topic and presents some general summaries regarding this patient population. Patients who experience a disease recurrence following a negative sentinel lymph node biopsy have a worse overall survival compared with patients with a positive sentinel lymph node biopsy. The implications and possible explanations for these findings are discussed in order to both underscore the need for in-depth investigation of local, regional or distant melanoma recurrence among patients following a true negative sentinel lymph node biopsy, as well as increased efforts to minimize the rate of false negative sentinel lymph node biopsies.

Entities:  

Keywords:  false-negative rate; melanoma; outcomes; recurrence; sentinel lymph node; survival

Year:  2015        PMID: 30190855      PMCID: PMC6094687          DOI: 10.2217/mmt.15.19

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN: 2045-0885


  34 in total

1.  Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.

Authors:  Nicholas C Lee; Andrew J Spillane; Tony C Y Pang; Lauren E Haydu; Roger F Uren
Journal:  Ann Surg Oncol       Date:  2011-07-21       Impact factor: 5.344

2.  Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.

Authors:  Zbigniew I Nowecki; Piotr Rutkowski; Anna Nasierowska-Guttmejer; Wlodzimierz Ruka
Journal:  Ann Surg Oncol       Date:  2006-10-03       Impact factor: 5.344

3.  Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma.

Authors:  Benjamin E Saltman; Ian Ganly; Snehal G Patel; Daniel G Coit; Mary Sue Brady; Richard J Wong; Jay O Boyle; Bhuvanesh Singh; Ashok R Shaha; Jatin P Shah; Dennis H Kraus
Journal:  Head Neck       Date:  2010-12       Impact factor: 3.147

4.  Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence.

Authors:  B M Clary; M S Brady; J J Lewis; D G Coit
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

5.  Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result.

Authors:  Edward L Jones; Teresa S Jones; Nathan W Pearlman; Dexiang Gao; Robert Stovall; Csaba Gajdos; Nicole Kounalakis; Rene Gonzalez; Karl D Lewis; William A Robinson; Martin D McCarter
Journal:  JAMA Surg       Date:  2013-05       Impact factor: 14.766

6.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

7.  Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.

Authors:  J E Gershenwald; M I Colome; J E Lee; P F Mansfield; C Tseng; J J Lee; C M Balch; M I Ross
Journal:  J Clin Oncol       Date:  1998-06       Impact factor: 44.544

8.  Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?

Authors:  Csaba Gajdos; Kent A Griffith; Sandra L Wong; Timothy M Johnson; Alfred E Chang; Vincent M Cimmino; Lori Lowe; Carol R Bradford; Riley S Rees; Michael S Sabel
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

9.  A basic introduction to fixed-effect and random-effects models for meta-analysis.

Authors:  Michael Borenstein; Larry V Hedges; Julian P T Higgins; Hannah R Rothstein
Journal:  Res Synth Methods       Date:  2010-11-21       Impact factor: 5.273

10.  Who is to blame for false-negative sentinel node biopsies in melanoma?

Authors:  Vernon K Sondak; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2010-03       Impact factor: 5.344

View more
  2 in total

1.  Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma.

Authors:  Richard J Straker; Michael J Carr; Andrew J Sinnamon; Adrienne B Shannon; James Sun; Karenia Landa; Kirsten M Baecher; Christian Wood; Kevin Lynch; Harrison G Bartels; Robyn Panchaud; Michael C Lowe; Craig L Slingluff; Mark J Jameson; Kenneth Tsai; Mark B Faries; Georgia M Beasley; Vernon Sondak; Giorgos C Karakousis; Jonathan S Zager; John T Miura
Journal:  Ann Surg Oncol       Date:  2021-04-22       Impact factor: 5.344

2.  Technologic (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region.

Authors:  Danique M S Berger; Nynke S van den Berg; Vincent van der Noort; Bernies van der Hiel; Renato A Valdés Olmos; Tessa A Buckle; Gijs H KleinJan; Oscar R Brouwer; Lenka Vermeeren; Baris Karakullukçu; Michiel W M van den Brekel; Bart A van de Wiel; Omgo E Nieweg; Alfons J M Balm; Fijs W B van Leeuwen; W Martin C Klop
Journal:  J Nucl Med       Date:  2021-02-26       Impact factor: 10.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.